INS and Hypoglycemia: As demonstrated in isolated rat islets [47], and later confirmed in human studies [103,[422], [423], [424]], GIP has negligible effects on insulin secretion under conditions of hypoglycemia, but strongly potentiates insulin secretion when circulating glucose levels reach or exceed 6–8 mmol/l [158,422].